Recombinant multi-species TGF/TGFB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TGF/TGFB2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
The Alternative Names of target: Cetermin,G-TSF,Glioblastoma-derived T-cell suppressor factor (G-TSF),LDS4,MGF,TGF,TGF-B2,TGF-beta2,TGFB2,TGFbeta2,Tgf-beta2,Tgfb-2,Tgfb2,Transforming growth factor beta-2 proprotein
Go
to TGF/TGFB2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T14143-Ag-1/ GM-Tg-hg-T14143-Ag-2 | Human TGF/TGFB2 protein | Human |
| GM-Tg-rg-T14143-Ag-1/ GM-Tg-rg-T14143-Ag-2 | Rat TGF/TGFB2 protein | Rat |
| GM-Tg-mg-T14143-Ag-1/ GM-Tg-mg-T14143-Ag-2 | Mouse TGF/TGFB2 protein | Mouse |
| GM-Tg-cynog-T14143-Ag-1/ GM-Tg-cynog-T14143-Ag-2 | Cynomolgus/Rhesus macaque TGF/TGFB2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T14143-Ag-1/ GM-Tg-felg-T14143-Ag-2 | Feline TGF/TGFB2 protein | Feline |
| GM-Tg-cang-T14143-Ag-1/ GM-Tg-cang-T14143-Ag-2 | Canine TGF/TGFB2 protein | Canine |
| GM-Tg-bovg-T14143-Ag-1/ GM-Tg-bovg-T14143-Ag-2 | Bovine TGF/TGFB2 protein | Bovine |
| GM-Tg-equg-T14143-Ag-1/ GM-Tg-equg-T14143-Ag-2 | Equine TGF/TGFB2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T14143-Ag-1/ GM-Tg-hg-T14143-Ag-2;
GM-Tg-rg-T14143-Ag-1/ GM-Tg-rg-T14143-Ag-2;
GM-Tg-mg-T14143-Ag-1/ GM-Tg-mg-T14143-Ag-2; GM-Tg-cynog-T14143-Ag-1/ GM-Tg-cynog-T14143-Ag-2; GM-Tg-felg-T14143-Ag-1/ GM-Tg-felg-T14143-Ag-2; GM-Tg-cang-T14143-Ag-1/ GM-Tg-cang-T14143-Ag-2; GM-Tg-bovg-T14143-Ag-1/ GM-Tg-bovg-T14143-Ag-2; GM-Tg-equg-T14143-Ag-1/ GM-Tg-equg-T14143-Ag-2 |
| Products Name | TGF/TGFB2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TGF/TGFB2 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TGF/TGFB2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.